logo
Select company
Select metric
$ -132.52MEarning Before Interest & Taxes (EBIT)
VS
Market
8
Sector
15
Industry
22
History
31
$ 34.63Close
$ 12.38 - $ 35.37 52-Week Range
Ticker Information

Ticker

ANAB

Company Name

ANAPTYSBIO INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ANAPTYSBIO INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ANAB - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -132.52M
3/31/2025$ -140.58M
12/31/2024$ -145.23M
9/30/2024$ -165.65M
6/30/2024$ -170.11M
3/31/2024$ -163.3M
12/31/2023$ -163.62M
9/30/2023$ -147.8M
6/30/2023$ -143.99M
3/31/2023$ -136.7M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ANAPTYSBIO INC's latest trailing twelve months (TTM) EBIT stands at $ -73.66M.
  • Over the past 5 years, ANAPTYSBIO INC's average EBIT has been $ -106.92M.
  • The median EBIT for ANAPTYSBIO INC during this period was $ -133.68M
  • ANAPTYSBIO INC reached its highest EBIT over the past 5 years at $ 8.39M.
  • The lowest EBIT recorded by ANAPTYSBIO INC in the same timeframe $ -170.11M

ANAPTYSBIO INC's EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT Benchmarks
CompanyEBIT
PHAT : PHATHOM PHARMACEUTICALS INC $ -257.49MNAGE : NIAGEN BIOSCIENCE INC $ 18.33MGYRE : GYRE THERAPEUTICS INC $ 7MCRMD : CORMEDIX INC $ 51.72MXNCR : XENCOR INC $ -134.76MTBPH : THERAVANCE BIOPHARMA INC $ 42.66MZYME : ZYMEWORKS INC $ -67.42MKURA : KURA ONCOLOGY INC $ -193.34MARCT : ARCTURUS THERAPEUTICS HOLDINGS INC $ -75.58MZVRA : ZEVRA THERAPEUTICS INC $ 29.88M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

ANAB - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -170.11M

Minimum

Jun 30, 2024

$ 8.39M

Maximum

Sep 30, 2021

$ -106.92M

Average

$ -133.68M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.62M with a standard deviation of $ 130.62M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 442.4M
average$ 28.62M
median$ 897.02K
std$ 130.62M